chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started to feel extremely fatigued. General malaise and when I coughed a lot, I was even throwing up. I did have some nausea but was surprised when I had to throw up because the nausea didn't seem all that bad. It lasted about four days. It seemed to resolved days after 4 or 5 days and then I had a period where I started to feel great. It started to come back in the last week (final) of September. The onset and symptoms were almost identical but this time it didn't let up and so I went for a good 5 days and eventually I went to Immediate Care - Friday, this past week. I did go see Dr. the week before on Wednesday - she ordered x-ray - they found a new area in the lower area in the right lung - she thought it might be pneumonia but she couldn't be sure. I hadn't had anything there before. On Friday before the last week of September, I saw my cardiologist and my medical oncologist (rechecking the cancer and she said I was doing very well).  At first, my cardiologist said everything looked good but was concerned about the Olmesartan and so she did say to go off of that and went back to Losartan (less potent) - this was after the first week of the health symptoms in September and before the last week of the adverse symptoms in Sept. when she thought everything was going okay again.  So then she said to go back on the Olmesartan but then told me to go off again when I was so sick again - she was a bit concerned with me taking it. I have hypo-natremia and that has been going on for 3-4 months. Not severe but the highish 120's. The final week in September when I was feeling sick it was maybe a bit worse - extreme fatigue, that same nausea and throwing up. I was continuing to take me dog out to walk but I would sometimes have difficulty making back to car - light headed and very, very weak. It wasn't clearing up on it's own. Over the month of September, I lost 14 lbs. When I had those two weeks of feeling so sick - I was eating very little, not drinking enough. I was in the high 150's and dropped to 138. Hospital for 5 days - pnuemonia; Olmesartan; nephremia - could have all been contributors. IV fluids - normal saline and then Sunday - Dr. - she prescribed sodium tablets and high protein diet and high calorie diet. I started to really improve on the diet and salt tablets. They collected a sputum sample - the day after I was hospitalized; was diagnosed on Sunday - I was in isolation then with that Diagnosis; standard treatment for IV  - gave me Vancomycin -they were very concerned that it may have been doing more harm than they initially realized. Zyvox - 600 mg tablet twice daily until finished - started that Tuesday and they discontinued the Vancomycin. WHen I came home, they also prescribed 1 mg at least for 3 times day of sodium tablets; that and the protein shakes have made a significant difference for me.  I feel much better now. I have improved dramatically - but each evening I do have a downward turn. I see Primary Care physician soon and he'll be doing another blood panel. On the day of the hospital release, they did give me a flu vaccine - October 5th. Had a sore arm after it.
Pain in extremity, Medication error. This case was reported by a nurse practitioner and described the occurrence of a sore arm in a 37 year old male patient who received hepatitis A inactivated & hepatitis B recombinant vaccine (Twinrix). On 05 February 2004, the patient received the first dose of Twinrix in his arm. On the same day, the patient experienced a sore arm. The outcome of the sore arm was unknown. Approxiamately for days later, on 09 February 2004, the patient inadvertently received the second dose of Twinrix (lot HAB276A6). This is sooner than the recommended interval of one month between the first and second doses On 09 February 2004, the patient also received measles, mumps and rubella virus vaccine (MMRII, Merk).
normal post vaccine symptoms 1st 48 hours.  fatigue, nausea, chills, headache.  On day 4, started feeling even worse, with shortness of breath and vomiting.  legs numb and tingling.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. The nurse reported that, on an unknown date, an unspecified amount of doses of VARIVAX (Merck) 0.5 ml, subcutaneous (lot # and expiration date were not reported) that underwent a temperature excursion was administered to an unspecified amount of patients. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
2ND DOSE WAS GIVEN AT DAY 14 INSTEAD OF DAY 28
Patient is a previously healthy fully-vaccinated 12 yo presenting with fever and chest pain. He had fevers to 101-102 6/17-6/19 that were responsive to antipyretics, then the chest pain started 6/20 and has been constant 5/10 pain since. It is burning and located substernal/between the scapula. Activity/breathing doesn't worsen the pain, but it is worst at night. He also reports a mild headache today that has since resolved. He went to his PCP today and had an EKG concerning for diffuse precordial ST elevations, so he was referred to the ED with concern for myo/pericarditis.   Of note, Patient received a second dose of the Pfizer COVID vaccine on 6/11.  He also travels every week and has removed ticks from himself that were unattached.  No known bites and no rashes.  He has not had any n/v/d, no abdominal pain, no cough/congestion/rhinorrhea, no syncope, no palpitations.   In the ED, he was well-appearing but tachycardic to the 120s with otherwise normal vitals. He developed fever to Tmax 38.3 that improved with Motrin. On exam he had rash concerning for erythema migrans with multiple satellite lesions. He an EKG with ST elevations in the inferolateral leads. POC US did not show any pericardial effusion. Cardiology was consulted (see consult note) and recommended troponin, which was 1.08, and CRP, which was 7.52.  CXR showed clear lungs and normal cardiac contours.  Hospital Course: Patient was admitted for further workup and management of his perimyocarditis. Given his erythema migrans rash and positive history of recent multiple tick exposure, we were concerned about Lyme disease (Lyme antibody pending) and sent testing for co-infection (Anaplasma, Ehrlichiosis) with smear negative for Babesia. We treated him empirically with doxycycline (given antibiotic allergies) and his rash improved. We also considered myocarditis following COVID vaccination. He had serial EKG's done which showed low-normal function, with EF=55.2%. He had serial troponins sent and they were downtrending at the time of discharge. He had chest pain that improved with PRN ibuprofen. He did not require steroids or IVIG. Cardiac MRI was completed prior to discharge and showed normal function and an area of subepicardial LV myocardial late gadolinium enhancement. consistent with myocarditis. At the time of discharge, he had no chest pain, was eating and drinking normally, and family was in agreement with plan for close Cardiology and Infectious Disease follow-up.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Bivalent vaccine (6yrs and older) that was left at room temp for less than 48 hours, but more than 24 hours and was also administered it after 12 hours post puncture to 2 adult female patients), PRODUCT STORAGE ERROR (Moderna Bivalent vaccine (6yrs and older) that was left at room temp for less than 48 hours, but more than 24 hours) and NO ADVERSE EVENT (no adverse event) in an adult female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 041H22A) for COVID-19 prophylaxis.     No Medical History information was reported.
lt arm swelled from elbow to shoulder;radiated to under axilla on lt side;pain in axilla;c/o feeling nauseated that noc;treated self w/NSAIDS & ice packs;c/o fever & chills that PM
Patient recieved 2nd vaccine on Tuesday 4/27/21 and on Thursday 4/29/21 patient woke up and noticed around 7am her palms were peeling (almost looks like a burn peal). Pain at injection site, swollen and itchy. On first day she experienced a slight fever but that subsided. No complains of any other symptoms. Patient didnt take or apply any medication to palms.    Advised to wash hands and she can apply aloe gel/aveeno lotion or lubriderm lotion to help the peel. Informed her that if she experiences any fever then she can take tylenol. 5/4-
Redness and swelling at injection site 5 1/2 x 4cm oval redness/warmth.  Tx: amoxicillin 875-125mg.
Information has been received from a nurse concerning a 20 year old female patient, for the pregnancy registry of GARDASIL, with a history of papanicolaou smear abnormal in 2006 and no known drug allergies/drug reactions, who on 14-MAY-2008 was vaccinated with the first dose of GARDASIL. On an unspecified date she was vaccinated with the second dose of GARDASIL and on 26-NOV-2008 was vaccinated with the third dose of GARDASIL. Subsequently it was determined to be pregnant by home pregnancy test. Last menstrual period was 19-OCT-2008 and estimated date of delivery was 26-JUL-2009. At the time of the report the patient had a prenatal blood work done (results were pending). The patient sought medical attention. Follow up information was received which reported that the patient had a vaginal delivery on 30-JUL-2009. Follow up information was received from a Physician's Assistant (P.A.) who reported that the patient had a spontaneous vaginal birth and delivered a healthy female on 30-JUL-2009, at 40 weeks (Estimated Gestational Age). It was reported that at the patient's postpartum visit it was noted that the baby was "thriving". The physician assistant stated there were no complications for the baby, and the mother only had mild anemia in her pregnancy, nothing more. It was unknown if the patient recovered from mild anemia. Additional information is not expected.
I was diagnosed with subcutaneous Emphysema. My symptoms were a large swollen bubbly neck that was air. I went to an urgent care and was sent to get an x-ray. After under a week it did go away. This also happened with my second dose as well which was Pfizer.
The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.; No Adverse event; Administered Moderna COVID-19 Vaccine after 30-day use by date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No Adverse event) in a 3-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 09-Aug-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Aug-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No Adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.), PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.) and NO ADVERSE EVENT (No Adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered Moderna COVID-19 Vaccine after 30-day use by date.) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 08-Jul-2022 and was administer on 09-Aug-2022.).    No concomitant medications were reported.   The healthcare professional was not aware of any symptoms for any patient after the vaccine was given.  No treatment details were reported.
No adverse event; got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (got vaccinated after BUD).    No concomitant medications were reported.  It was reported that, the patient received vaccine after the beyond use-by date.  No treatment medications were reported.
This is a spontaneous report from a contactable consumer. A 58-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL8982), via an unspecified route of administration by injection once to left arm, upper part, on 26Jan2021 at a single dose for COVID-19 immunization. The patient has no medical history. There were no concomitant medications. The patient experienced tingling on right side by cheek bone on 27Jan2021 and she did not have it yesterday, and the shot was on the left side, later clarified as the left arm. The outcome of the event was not recovered.
within 24 hours had a full blown case of the flu; Initial information regarding an unsolicited valid non-serious social media case through global digital media received from a patient on 07-Dec-2020.  This case is linked to case 2020SA355506.  This case involves Adult patient of unspecified gender who within 24 hours had a full blown case of the flu (influenza), while patient received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was not reported.  On an unknown date, the patient received a dose 1 of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site as a prophylactic vaccination.  On an unknown date, the patient received a dose 2 of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route at an unknown administration site as a prophylactic vaccination.  On an unspecified date, (latency unknown) after the administration of vaccine, the patient had 2 flu shots and both the times within 24 hours patient had full blown case of flu (influenza).  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  At the time of reporting, outcome of the event was unknown.  There will be no information regarding the batch number of the case.
Initial report received from a healthcare professional on 01 November 2013. A 59-year-old female patient who had diabetes at the time of vaccination and no known allergies, had received an intradermal first dose of FLUZONE ID (lot number: UT4721BA) on 19 September 2013. On 19 September 2013, the patient reported palm sized area of redness was at injection site day of vaccination, now has 1cm slightly tender nodule at site. Laboratory investigations and corrective medications were not reported. At the time of this report the patient did not recover from the event. Documents held by sender: None. Follow-up information was received from the healthcare professional on 07 August 2014. No new information was reported. Documents held by sender: none.
Received rash, hard bump, redness, and itching at injection site on Day 7 following injection. Also experienced headache and dizziness minutes after receiving injection on site. Extreme fatigue lasting days, but seemed to improve  by Day 6. Vestibular Condition - Meniere's Disease - Tinnitus started to occur and is still ongoing on Day 8.
Patient was anxious and declined to have their third dose of GARDASIL 9; This spontaneous report was received from a Registered Nurse and refers to an adult female in her mid-twenties (reported as believed to be 25 or 26 years old).  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On unknown dates, the patient was vaccinated with first and second doses of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (dose, lot #, expiry date, and route of administration were not provided).  The reporter informed that the patient was scheduled to receive the third dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) on 22-APR-2023, but that she was anxious and declined to have her third dose of the mentioned vaccine on that date (Anxiety). The reporter was unable to provide any additional details regarding this event as it was unknown. No additional adverse events were reported and there were no product quality complaints. No further information was provided. At the time of this report, the outcome of anxiety was unknown.  Action taken with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) regarding anxiety was not applicable.  The causal relationship between anxiety and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was not reported (unknown).
Temperature elevation to 40C, starting within hours of Prevnar vaccination and lasting 3 days.
anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest that lasted intermittently for 4 days; This is a spontaneous report from a contactable consumer (the patient).  A 75-year-old male patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9264), via an unspecified route of administration on 05Feb2021 at 11:10 AM  (at the age of 75 years), as a single dose for COVID-19 immunization. Medical history included kidney transplant. Concomitant medication included tacrolimus, mycophenolate mofetil (MYCOPHENOLATE), prednisone. Historical vaccine included Dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL8982), on 14Jan2021 for COVID-19 immunization). On 05Feb2021 at around 18:00 PM, the patient had what he believed was an anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest (he clarified that upper chest as where the neck meets the chest. It may have been a little lower, but not that far down that he would have worried. It was the upper chest where the neck meets the chest. Not in the chest to the left or right). It lasted intermittently for 4 days. He reported that it was not continuous, it would come for 2-3 hours dissipate and then come again. It wasn't all day and all night. He reported "I'm better now". The clinical outcome of anaphylactic reaction with tightness around his jaw area, ears, and throat, and tightness in upper chest  was recovered on 10Feb2021.
NEGATIVE ANTIBODY TEST POST VACCINATION 3 WEEKS LATER; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 27-APR-2021, the subject experienced negative antibody test post vaccination 3 weeks later. Laboratory data included: SARS-CoV-2 IgG antibody test (NR: not provided) negative, and SARS-CoV-2 IgM antibody test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of negative antibody test post vaccination 3 weeks later was not reported. This report was non-serious.
fever up to 105 & vomiting on 11MAY96;seen in ER & adm to r/o septicemia by ER staff;pt recv IV fluids was afeb 12MAY96 & was d/c home;pt well since then;
PATIENT RECEIVED FIRST DOSE AT ANOTHER  PHARMCY IN ON 7-12-21. SHE CAME IN FOR HER SECOND DOSE AT  PHARMACY IN  ON 7-28-21 NOT REALIZING SHE WAS TO WAIT 28 DAYS IN BETWEEN DOSES  SHE DIDNT PRESENT HER VACCINATION CARD INITAILLY BUT DID UPON RECEIVING HER VACCINATION THE PHARMACIST IN CHARGE AND TECHNICIAN DIDNT REALIZE THE DOSE WAS 12 DAYS TOO SOON BEFORE GIVING HER THE VACCINATION. HER PRIMARY CARE DR AND CARDIOLOGIST WERE CONSULTED ALONG WITH THE MANUFACTURER. NOT ADVERSE EFFECTS WERE OBSERVED WE ARE CHECKING ON PT DAILY
pt recv vax  6DEC96 & slept longer than nl;mom checked pt @ 415PM:pt rolled eyes back &  began slow jerking movements;resp became shallow, gasping, head fell back;sz, fingers blue;listless, staring, pale;irritable;t103.6;restless;
That Saturday after getting injection I woke up 4 to go to the food pantry and I couldn't get out of bed. I was  dizzy, and I felt like I had been hit by a baseball bat, and I just couldn't out of bed. No fever. The next day it was the same thing, I got up to go to church. I was feeling unwell. After mass I went home. I couldn't do my usual Sunday activities.
89-year-old male who was previously living in an independent facility presents to the hospital on 1//23 (vaccinated on 12/28/2022) with a chief complaint of bradycardia, rates in the 30s, AKI, supratherapeutic INR, right lower lobe infiltrate.  He did require dopamine and Lasix in the ICU.  Ultimately, he was discharged on 1/10/2023 to skilled nursing facility (previously independent).  On 1/24 patient was readmitted to this hospital with a chief complaint of altered mental status with agitation requiring Haldol.  At this time the patient's POA elected to pursue comfort care for this patient.  On 1/25/2023 patient died.  To reiterate patient did have a seemingly rapid decline in overall health status during the short timeframe status post COVID-19 vaccination.
CHEST PAIN WITH COUGH, FATIGUE, CONGESTION, MINOR SORE THROAT,
pt recv vax 3OCT96 & 11OCT96 pt exp chickenpox w/a rash on lower lt leg; approx 1 day later pt devel fever;17OCT96 pt devel blotchy erythematous lesions/eruptions on the face;
Information has been received from a physician concerning a female patient in her eighties with no medical history who on 14 Nov 2006 was vaccinated with a 0.65 mL dose of Zostavax. There was no concomitant medication. On 23 Nov 2006, the patient presented to the physician's office with a varicella like rash after vaccination. She had lesions all over her body. The reporter did not know the number of lesions. The lesions lasted three days and the patient completely recovered on 26 Nov 2006. A product quality complaint was not involved. Additional information has been requested.